ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Pathos
Pathos is an innovative biotech company utilizing AI and genomics to transform oncology drug development. They leverage large datasets and advanced computational methods to inform clinical decisions, focusing on improving patient outcomes through precise and predictive biomarker insights.
Headquarters
New York, New York, United States
Company Size
11-50 employees
Founded
2022
Pathos is an AI-enabled, clinical-stage biotech company redefining drug development for precision oncology. The company integrates advanced AI technology, biological modeling, and the largest collection of multimodal oncology patient data to make clinical trials smarter, faster, and more precise. By identifying the right patient populations and building a repeatable development engine, Pathos aims to reduce trial failures and accelerate the delivery of precision therapies through biopharma partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pathos.
38% above the average for this role
Computational Biologist
Dana-Farber Cancer Institute
Director of Oncology Genomics & Data Science
GSK plc
Principal Scientist, Bioinformatics
Nkarta, Inc.
Computational Biologist
University of Chicago
2027 Future Talent Program - Translational Genome Analytics - Co-op
MSD
Senior Scientist (m/f/d), Computational Pathology Biomarker Lead (Oncology)
AstraZeneca